Bendamustine for the first-line treatment of chronic lymphocytic leukaemia

  • Technology appraisal guidance
  • TA216
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that bendamustine is recommended as an option for treating chronic lymphocytic leukaemia.

ISBN: 978-1-4731-6664-6